Get the Stockscreener App
1.47
8.89%
0.12
After Hours:
1.36
-0.11
-7.48%
Vivos Therapeutics Inc stock is traded at $1.47, with a volume of 391.56K.
It is up +8.89% in the last 24 hours and up +18.55% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$1.35
Open:
$1.35
24h Volume:
391.56K
Relative Volume:
2.33
Market Cap:
$17.38M
Revenue:
$17.32M
Net Income/Loss:
$-17.10M
P/E Ratio:
-0.7448
EPS:
-1.9737
Net Cash Flow:
$-15.37M
1W Performance:
+22.50%
1M Performance:
+18.55%
6M Performance:
-53.33%
1Y Performance:
-32.88%
1-Day Range:
$1.33
$1.54
1-Week Range:
$1.15
$1.54
52-Week Range:
$1.085
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.47 | 15.96M | 17.32M | -17.10M | -15.37M | -1.9737 |
ABT
Abbott Laboratories
|
101.56 | 175.59B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
341.24 | 132.47B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.10 | 113.14B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
64.61 | 94.85B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
78.20 | 45.09B | 6.07B | 1.06B | 1.34B | 1.8063 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
Vivos Therapeutics Reports Full Year 2025 Financial Results - marketscreener.com
Vivos grows on sleep apnea services, but operating loss hits $19.9M - Stock Titan
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results - National Today
Vivos Therapeutics, Inc. to Release Full Year 2025 Financial Results and Conduct Conference Call on April 15, 2026 - Quiver Quantitative
Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call - marketscreener.com
Vivos investors get 2025 results and strategy update at 5 p.m. ET - Stock Titan
Broadcom, Vivos Therapeutics and 3 stocks to watch heading into Monday - MSN
New to The Street to Broadcast on Fox Business on Monday, April 13, Featuring Virtuix Holdings (NASDAQ:VTIX), Medicus Pharma (NASDAQ:MDCX), YY Group Holdings (NASDAQ:YYGH), Vivos Therapeutics (NASDAQ:VVOS), and Stardust Power (NASDAQ - ACCESS Newswire
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Hilton Head Island Packet
Vivos Therapeutics (VVOS) 10% holder reports large stock and warrant stakes - Stock Titan
VVOS Stock Chart | VIVOS THERAPEUTICS INC (NASDAQ:VVOS) - ChartMill
Resistance Check: Can Vivos Therapeutics Inc maintain its current growth rate2026 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
VVOS|Vivos Therapeutics Inc|Price:1.190|Chg%:-0.05 - TradingKey
VVOS Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Vivos Therapeutics closes $2.25M private placement with Seneca By Investing.com - Investing.com Canada
Vivos Therapeutics closes $2.25M private placement with Seneca - Investing.com
Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners - marketscreener.com
Portfolio Update: How does Vivos Therapeutics Inc score in quality rankingsTrade Exit Report & Accurate Technical Buy Alerts - baoquankhu1.vn
Broadcom, Vivos Therapeutics And 3 Stocks To Watch Heading Into Monday - Sahm
Vivos Therapeutics Enters Securities Purchase Agreement with V-CO Investors 3 LLC and Issues New Warrants – Form 8-K Filing Details - Minichart
VVOS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
VVOS Technical Analysis & Stock Price Forecast - Intellectia AI
If You Invested $1,000 in Vivos Therapeutics Inc (VVOS) - Stock Titan
Vivos Therapeutics Completes Private Placement to Bolster Liquidity - TipRanks
Vivos Therapeutics Secures $0.85M PIPE, Converts $1.4M Bridge Note With Seneca Affiliate - TradingView — Track All Markets
Vivos Therapeutics (NASDAQ: VVOS) gets $850,000 PIPE cash plus $1,400,000 bridge note conversion - Stock Titan
Why did Vivos Therapeutics (VVOS) stock jump over 21% after hours - MSN
Form 8-KCurrent report - ADVFN
Vivos Therapeutics investor V-Co investors 3 LLC buys shares worth $1.8m By Investing.com - Investing.com
Why Did Vivos Therapeutics (VVOS) Stock Jump Over 21% After Hours - Benzinga
VVOS | Vivos Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Vivos Therapeutics (NASDAQ: VVOS) investor buys stock, pre-funded warrants - Stock Titan
Michael C. Skaff Discloses Investment at Vivos Therapeutics with 19.9% Stake - TradingView — Track All Markets
Investor group (NASDAQ: VVOS) funds Vivos with $2.39M PIPE and warrants - Stock Titan
Vivos Therapeutics Delays Annual Filing Amid Expansion - TipRanks
Vivos Therapeutics’ Supported Practices Achieve In-Network Status in Nevada - Sleep Review
Vivos Therapeutics (NASDAQ: VVOS) delays 2025 Form 10-K, cites SCN acquisition - Stock Titan
Buyback Watch: What are Vivos Therapeutics Incs earnings expectations2026 Recap & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
Vivos Therapeutics, Inc. announced that it has received $2.389957 million in funding from V-Co Investors 3 LLC - marketscreener.com
Vivos Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Earnings Risk: Can Vivos Therapeutics Inc withstand a market correction2026 Drop Watch & Breakout Confirmation Alerts - baoquankhu1.vn
Vivos Therapeutics Inc (referred to as Vivos Therapeutics) recently disclosed a comprehensive cost optimization strategy. - Bitget
Vivos Therapeutics gains Nevada insurance network access By Investing.com - Investing.com Canada
Vivos Therapeutics gains Nevada insurance network access - Investing.com
Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market - The Manila Times
Vivos Therapeutics Announces In-Network Insurance Coverage for OSA Treatments in Nevada and Initiates Cost Reduction Measures - Quiver Quantitative
More Las Vegas sleep apnea patients gain coverage as Vivos cuts costs - Stock Titan
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.40%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):